SCHEMBL2988968

SCHEMBL2988968

N#Cc1ccc(CB(O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 2/20 0.52
▸ CYP2A6 P11509 2/20 0.52
▸ ENPP2 Q13822 1/20 0.52
▸ CA12 O43570 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA3 P07451 1/20 0.46
▸ CA6 P23280 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ CA14 Q9ULX7 1/20 0.46
▸ IDO1 P14902 2/20 0.46
▸ SAE1 Q9UBE0 1/20 0.43
▸ UBA2 Q9UBT2 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ CYP19A1 P11511 3/20 0.42
▸ KCNJ1 P48048 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ CTBP2 P56545 1/20 0.42
▸ MMP3 P08254 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP11B1 P15538 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12342203 0.75 ENPP2 (0.53) ENPP2CYP19A1ALDH1A1CYP11B1CYP11B2
SCHEMBL92970 0.73 LOXL2 (0.58) LOXL2CYP2A6ENPP2CA12CA2
SCHEMBL31532974 0.72 MAOB (0.47) LOXL2CYP2A6ENPP2CA12CA2
SCHEMBL1344068 0.72 LOXL2 (0.65) LOXL2CYP2A6CA12CA2CA3
SCHEMBL1004267 0.72 LOXL2 (0.64) LOXL2CYP2A6CA12CA2CA3
Hydrogen Sulfide SCHEMBL27473257 0.71 LOXL2 (0.56) LOXL2CYP2A6ENPP2CA12CA2
SCHEMBL27707919 0.71 LOXL2 (0.56) LOXL2CYP2A6ENPP2CA12CA2
SCHEMBL45942 0.71 CA2 (0.69) LOXL2CYP2A6ENPP2CA12CA2
SCHEMBL2503454 0.71 CA2 (0.69) LOXL2CYP2A6ENPP2CA12CA2
Water SCHEMBL28189314 0.71 CA2 (0.69) LOXL2CYP2A6ENPP2CA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119931075-A Synthesis method of fluorescent hydrogen bond organic framework material based on thieno [3,2-b ] thiophene and application of fluorescent hydrogen bond organic framework material in separation of toluene and methylcyclohexane 江西科技师范大学 2025-05-06 — — CN claimed
CN-120189396-A Pyruvate inhalation aerosol for treating malignant pleural effusion caused by lung cancer and preparation method thereof 江苏长泰药业股份有限公司 2025-06-24 — — CN disclosed
CN-120136786-A Anthracene derivative blue luminescent material based on spirofluorene and preparation method and application thereof 广东工业大学 2025-06-13 — — CN disclosed
CN-119931075-A Synthesis method of fluorescent hydrogen bond organic framework material based on thieno [3,2-b ] thiophene and application of fluorescent hydrogen bond organic framework material in separation of toluene and methylcyclohexane 江西科技师范大学 2025-05-06 — — CN disclosed
CN-119462425-A Organic compound, luminescent material, organic electroluminescent device and display panel 广东聚华印刷显示技术有限公司 2025-02-18 — — CN disclosed
CN-118930489-A Pyrene imidazole blue luminescent material based on 1, 8-position modification 南京工业大学 2024-11-12 — — CN disclosed
CN-118373840-A Bromine-containing and ring-combined BODIPY photosensitizer, preparation method and application 三峡大学 2024-07-23 — — CN disclosed
CN-118344321-A Gamma-pyrone derivative and synthetic method and application thereof 武汉轻工大学 2024-07-16 — — CN disclosed
CN-118324660-A Pyrene derivative and preparation method and application thereof 中国石油化工股份有限公司 2024-07-12 — — CN disclosed
CN-113527302-B Compound and application thereof 北京鼎材科技有限公司 2024-05-24 — — CN disclosed
CN-116253753-A Luminescent material, application thereof and organic electroluminescent device comprising luminescent material 清华大学 2023-06-13 — — CN disclosed
CN-113788846-B Tricyclic thiazolo [5,4-d ] pyrimidinone derivative and application thereof 中国科学院新疆理化技术研究所 2023-05-02 — — CN disclosed
CN-114085195-B Biodegradable film material with light conversion function, preparation method thereof and film doping material thereof 浙江播下环保科技有限公司 2022-06-14 — — CN disclosed
CN-114085195-A Biodegradable film material with light conversion function, preparation method thereof and film doping material thereof 浙江播下环保科技有限公司 2022-02-25 — — CN disclosed
CN-110446711-B Inhibitors of influenza virus replication and uses thereof 广东东阳光药业有限公司 2022-02-15 — — CN disclosed
US-20100317854-A1 NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-12-16 — — US disclosed
US-7781470-B2 Aminodicarboxylic acid derivatives having pharmaceutical properties BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-08-24 — — US disclosed
US-20090203906-A1 NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES BAYER AKTIENGESELLSCHAFT (DE) 2009-08-13 — — US disclosed
US-7087644-B1 Derivatives of dicarboxylic acid having pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2006-08-08 — — US disclosed
US-20060094769-A1 Novel aminodicarboxylic acid derivatives having pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2006-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203906-A1 NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES DDC, AADAT, PTGIS LOXL2 100/4885CYP2A6 252/4885ENPP2 109/4885
US-20100317854-A1 NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES DDC, AADAT, PTGIS LOXL2 100/4885CYP2A6 252/4885ENPP2 109/4885
US-20060094769-A1 Novel aminodicarboxylic acid derivatives having pharmaceutical properties DDC, AADAT, PTGIS LOXL2 100/4885CYP2A6 252/4885ENPP2 109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback